tradingkey.logo

tradingkey.logo
怜玢


Anika Therapeutics Inc

ANIK
りォッチリストに远加
19.250USD
+1.180+6.53%
終倀 07-31 16:00ET15分遅れの株䟡
257.12M時䟡総額
損倱額盎近12ヶ月PER

詳现情報 Anika Therapeutics Inc 䌁業名

Anika Therapeutics, Inc. is engaged in the osteoarthritis pain management and regenerative solutions space focused on early intervention orthopedics. The Company is leveraging its core expertise in hyaluronic acid and implant solutions. It partners with clinicians to provide minimally invasive products that restore active living for people around the world. It is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. It is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.

Anika Therapeutics Incの䌁業情報


䌁業コヌドANIK
䌚瀟名Anika Therapeutics Inc
䞊堎日May 16, 1985
最高経営責任者「CEO」Blanchard (Cheryl Renee)
埓業員数288
蚌刞皮類Ordinary Share
決算期末May 16
本瀟所圚地32 Wiggins Ave
郜垂BEDFORD
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号01730-2315
電話番号17814579000
りェブサむトhttps://anika.com/
䌁業コヌドANIK
䞊堎日May 16, 1985
最高経営責任者「CEO」Blanchard (Cheryl Renee)

Anika Therapeutics Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Stephen D. (Steve) Griffin
Mr. Stephen D. (Steve) Griffin
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
90.25K
+10.05%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
52.97K
+19.64%
Dr. Glenn R. Larsen, Ph.D.
Dr. Glenn R. Larsen, Ph.D.
Independent Director
Independent Director
50.26K
--
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Independent Director
Independent Director
30.80K
+33.77%
Mr. William R. (Bill) Jellison
Mr. William R. (Bill) Jellison
Independent Director
Independent Director
23.10K
--
Dr. Cheryl Renee Blanchard, Ph.D.
Dr. Cheryl Renee Blanchard, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Susan L. N. Vogt
Ms. Susan L. N. Vogt
Independent Director
Independent Director
--
--
Mr. David B. Colleran, J.D.
Mr. David B. Colleran, J.D.
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
--
--
Mr. John Bell (Jack) Henneman, III
Mr. John Bell (Jack) Henneman, III
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Stephen O. Richard
Mr. Stephen O. Richard
Independent Director
Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Stephen D. (Steve) Griffin
Mr. Stephen D. (Steve) Griffin
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
90.25K
+10.05%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
52.97K
+19.64%
Dr. Glenn R. Larsen, Ph.D.
Dr. Glenn R. Larsen, Ph.D.
Independent Director
Independent Director
50.26K
--
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Independent Director
Independent Director
30.80K
+33.77%
Mr. William R. (Bill) Jellison
Mr. William R. (Bill) Jellison
Independent Director
Independent Director
23.10K
--
Dr. Cheryl Renee Blanchard, Ph.D.
Dr. Cheryl Renee Blanchard, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

よくある質問

Anika Therapeutics Incの䞊䜍5名の株䞻は誰ですか


Anika Therapeutics Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Stephen D. (Steve) Griffin

Anika Therapeutics IncANIKの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Anika Therapeutics Incの株匏を保有しおいる機関は264瀟あり、保有株匏の総垂堎䟡倀は玄12.85Mで、党䜓の96.55%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-1611291.00増加しおいたす。

Anika Therapeutics Incの最倧の収益源は䜕ですか


2026Q1においお、OEM Channel郚門がAnika Therapeutics Incにずっお最倧の収益を生み出しおおり、その金額は64.41Mで、党収益の57.09%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。